中国生命集团（股票代码：08296）于2026年6月1日向香港联合交易所有限公司提交了截至2026年5月31日的证券变动月报表。
月报显示，公司于报告期末法定及注册股本维持在1,000,000,000股，面值每股1港元，合计对应股本总额港币1,000,000,000，与上月底持平。普通股已发行股本则同样保持94,500,000股，库藏股份数目为0股，二者均未发生任何增减变动。
在股份期权方面，截至本月末，公司购股权计划所对应的股份期权期末结存数量为1,853,200份，报告期内无行权、授出或失效等变化。公司可转换债券规模维持在港币18,160,000，转换价为每股港币1.26，报告期内也无新增发行或转股记录。公司确认其公众持股量符合相关要求，股权结构维持稳定。
公告同时表示，上述股份变动事项已遵守香港联交所《上市规则》及其他法律法规要求。董事会授权相关证券发行及库藏股份事务，所有权文件已按照规定完成或预计在合规范围内完成。该月报由公司秘书朱健明签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.